Development of therapeutic anti-JAGGED1 antibodies for cancer therapy

The role of Notch signaling and its ligand JAGGED1 (JAG1) in tumor biology have been firmly established, making them appealing therapeutic targets for cancer treatment. Here we report the development and characterization of human/rat-specific JAG1-neutralizing monoclonal antibodies. Epitope mapping...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cancer Ther
Autors principals: Masiero, Massimo, Li, Demin, Whiteman, Pat, Bentley, Carol, Greig, Jenny, Hassanali, Tasneem, Watts, Sarah, Stribbling, Stephen, Yates, Jenna, Bealing, Ellen, Li, Ji-Liang, Chillakuri, Chandramouli, Sheppard, Devon, Serres, Sébastien, Sarmiento-Soto, Manuel, Larkin, James, Sibson, Nicola R., Handford, Penny A., Harris, Adrian L., Banham, Alison H.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7611158/
https://ncbi.nlm.nih.gov/pubmed/31395687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-18-1176
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars